Article

Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients

2021-12-14

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The SARS-CoV-2 Omicron variant, designated as a Variant of Concern(VOC) by the World Health Organization, carries numerous spike protein mutations which have been found to evade neutralizing antibodies elicited by COVID-19 vaccines. The susceptibility of Omicron variant by vaccine-induced neutralizing antibodies are urgently needed for risk assessment. <h4>Methods</h4> Omicron...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 12b4dc50-53d6-5fe4-87bc-54e44dd1418d
DOI: 10.1101/2021.12.13.21267668

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipientsDOI 10.1101/2021.12.13.21267668Read

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemicSemantic proximity Read

Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic AntibodiesSemantic proximity Read

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSemantic proximity Read

Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.Semantic proximity Read

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccinesSemantic proximity Read

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinationsSemantic proximity Read

Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particlesSemantic proximity Read

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathwaySemantic proximity Read

Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccinesSemantic proximity Read

Mutations in the spike RBD of SARS-CoV-2 omicron variant may increase infectivity without dramatically altering the efficacy of current multi-dosage vaccinationsSemantic proximity Read

Plasma neutralization properties of the SARS-CoV-2 Omicron variantSemantic proximity Read

Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.Semantic proximity Read